Japan approves remdesivir for coronavirus treatment

May 08, 2020 | News On Japan

May 08, 2020 (Japan Today) - Japan on Thursday approved the antiviral drug remdesivir to treat coronavirus patients, the government said, with an eye to approving another medication Avigan this month.

This makes Japan the second country to approve the drug after U.S. regulators authorized it on May 1 for emergency use against severe cases of COVID-19.

Prime Minister Shinzo Abe said last week the government was getting ready to give a speedy green light to the experimental drug developed by U.S. firm Gilead Sciences.

The U.S. go-ahead came after a major clinical trial showed remdesivir -- originally developed to treat Ebola -- shortened the time to recovery in some patients by a third.

The difference in mortality rate was not statistically significant.

Remdesivir, which is administered by injection, was already available to some patients who enrolled in clinical trials around the world.

As for Avigan, developed by Japanese firm Fujifilm Toyama Chemical, Suga said the government "aims to approve it this month" if a clinical trial involving 100 patients proves effective.

The drug, whose generic name is favipiravir, was approved for use in Japan in 2014 but only in flu outbreaks that are not being effectively addressed by existing medications.

It is not available on the market and can only be manufactured and distributed at the request of the Japanese government.

Typhoons No. 28 and 29 Bring High Waves to Japan's Pacific Coast

Two typhoons moving across the Pacific southeast of Japan are expected to remain well away from the Japanese mainland, but powerful swells could bring rough seas to a wide stretch of the country's Pacific coastline throughout the three-day holiday weekend, according to forecasts updated at 3 a.m. on October 10.

Cyberattacks Spread Across Japan

A series of cyberattacks has disrupted business operations and exposed millions of customer records across Japan, with a ransomware attack on a cloud service provider affecting 495 companies and local governments nationwide, while convenience store operator Lawson has disclosed a separate breach involving more than 2.15 million personal information records.

Japan's First 360-Degree Projection Mapping Opens in Osaka

Japan's first 360-degree projection mapping show will open at the Osaka City Museum of Fine Arts on October 10, transforming the historic building into an immersive world of light, music, and seasonal imagery, with organizers hoping the attraction will also help stimulate the city's nighttime economy.

Tokyo University Professor Wins Nobel Prize in Chemistry

Tokyo University of Science professor emeritus Kenzo Soai has been awarded this year's Nobel Prize in Chemistry together with French chemist Henri B. Kagan for discoveries that transformed scientists' understanding of how chemical reactions can favor one of two mirror-image forms of a molecule.

US Military Halts All Okinawa Operations for 48 Hours

The US military suspended activities by all forces stationed in Okinawa for 48 hours from noon on October 7, an unusual measure following the arrest of a US Marine in connection with a robbery and murder case that has renewed scrutiny of crimes involving American service members.

MEDIA CHANNELS

MORE Society NEWS

Most Sightings of Fugitive Yoichi Hatta Reported in Kanto

Police in Oita Prefecture have revealed that the Kanto region accounts for the largest number of reported sightings of Yoichi Hatta, a fugitive wanted in connection with a fatal hit-and-run incident in Beppu in 2022, with authorities preparing to distribute new wanted posters nationwide from November as the search enters its fifth year.